Cue Biopharma Net Non-Operating Interest Income Expense (Quarterly) Analysis

Cue Biopharma, Inc. (CUE)

0.2959 -0.01 (-2.02%) USD | NASDAQ | Jan 20, 16:00

0.2959 0.00 (0.00%) After-Hours: 19:11

View Net Non-Operating Interest Income Expense (Quarterly) for CUE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	Upgrade
Puma Biotechnology, Inc.	Upgrade
Mersana Therapeutics, Inc. (DELISTED)	Upgrade
Adaptive Biotechnologies Corp.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade